[Treatment and prevention of venous thromboembolic disease: what's new?].
Venous thromboembolic (VTE) disease is frequent and questions regarding its treatment or prevention are numerous. This review is aimed at summarizing and pointing out the novelties on VTE treatment and prevention recently published in the Chest journal earlier this year (8th edition of ACCP guidelines). Generally, the aim of guidelines and of this review as well, is to offer guidance to practictioners in making the most appropriate choice for treating or preventing VTE. They are not intended for strict application and doctors will always have to decide individually case by case taking into account patients preference and the risk-benefit balance.
Rey
Marie-Antoinette
MA
Service d'angiologie, CHUV, 1011 Lausanne. marie-antoinette.rey@chuv.ch
Bron
Cédric
C
Haesler
Erik
E
Mazzolai
Lucia
L
D000925:Anticoagulants / Q000627:therapeutic use; D005260:Female; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy / Q000517:prevention & control; D011655:Pulmonary Embolism / Q000517:prevention & control; D054556:Venous Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control*
D000925:Anticoagulants